The induction of ferroptosis is also resistant to chemoradiotherapy in cancer, and the transcriptional coactivator, Yes-associated protein, is activated in drug-resistant cancer cells, thereby enhancing ferroptosis sensitivity by activating two iron-promoting factors, ACSL4 and TFRC (Yang et al., 2019). Here, ACSL4 is linked to cancer.